Showing 2,681 - 2,700 results of 21,342 for search '(( ((significant effects) OR (significant effect)) decrease ) OR ( significant decrease decrease ))', query time: 0.67s Refine Results
  1. 2681
  2. 2682
  3. 2683
  4. 2684
  5. 2685
  6. 2686
  7. 2687
  8. 2688
  9. 2689
  10. 2690
  11. 2691

    Moderating effect of CSR-sensitivity (RCSR). by Hao Wang (39217)

    Published 2025
    “…This study employs fixed-effects models for a panel data. The findings reveal that minimum wage increases are significantly associated with a reduction in both strategic CSR and responsive CSR. …”
  12. 2692

    Moderating effect of CSR-sensitivity (SCSR). by Hao Wang (39217)

    Published 2025
    “…This study employs fixed-effects models for a panel data. The findings reveal that minimum wage increases are significantly associated with a reduction in both strategic CSR and responsive CSR. …”
  13. 2693
  14. 2694

    Effects of intracisternal drug administration on the immunoreactivity of D2 receptor. by Hiroharu Maegawa (8087543)

    Published 2025
    “…N = 5 in each group. A significant decrease was found in the ION-CCI + CGRP Ab group as compared to the ION-CCI, ION-CCI + vehi, ION-CCI + CGRP, and ION-CCI + ctrl IgG groups. ** <i>p</i> < 0.01, * <i>p</i> < 0.05 compared to ION-CCI + CGRP Ab group. …”
  15. 2695
  16. 2696
  17. 2697

    Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i> by Razia Rashid Rahil (22772495)

    Published 2025
    “…(B, C) Summarized bar graph showed EVO significantly decreased calcium deposition and calcium content in CER treated P<sub>i</sub>-induced VSMCs. …”
  18. 2698
  19. 2699
  20. 2700

    Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx by Tengxiang Zhao (20749475)

    Published 2025
    “…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”